Skip to content
← Back to this collection

PUBLICATIONS · 24687829

Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 May 1
First author
Stockler MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299.
    note
    Source null
    related pmid
    24637996
    relationship
    Comment in

Authors and identifiers

  1. name
    Stockler MR
    type
    Author
  2. name
    Hilpert F
    type
    Author
  3. name
    Friedlander M
    type
    Author
  4. name
    King MT
    type
    Author
  5. name
    Wenzel L
    type
    Author
  6. name
    Lee CK
    type
    Author
  7. name
    Joly F
    type
    Author
  8. name
    de Gregorio N
    type
    Author
  9. name
    Arranz JA
    type
    Author
  10. name
    Mirza MR
    type
    Author
  11. name
    Sorio R
    type
    Author
  12. name
    Freudensprung U
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Stockler MR
    type
    Author
  2. name
    Hilpert F
    type
    Author
  3. name
    Friedlander M
    type
    Author
  4. name
    King MT
    type
    Author
  5. name
    Wenzel L
    type
    Author
  6. name
    Lee CK
    type
    Author
  7. name
    Joly F
    type
    Author
  8. name
    de Gregorio N
    type
    Author
  9. name
    Arranz JA
    type
    Author
  10. name
    Mirza MR
    type
    Author
  11. name
    Sorio R
    type
    Author
  12. name
    Freudensprung U
    type
    Author
bibliography ids
  1. nci-bib-23d54d232287b7f3fd8f17c4
book metadata
content sha256
361f11bccbf53e4be9cfd7bf1f11f508482db1733b4453f38ca53014358bd18b
document type
citation
dois
  1. 10.1200/JCO.2013.51.4240
electronic publication date
display
2014 Mar 31
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24687829
immutable id
pubmed:24687829@361f11bccbf53e4be9cfd7bf1f11f508482db1733b4453f38ca53014358bd18b
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1309-16
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299.
    note
    Source null
    related pmid
    24637996
    relationship
    Comment in
outcomes validated
false
pmid
24687829
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
a405a01e1a239c5f2793b9727405ae2d1b06dc4313ba19254fe5451d744780e6
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 May 1
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24687829/
title
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.

Preserved source evidence · Not medical advice